(MedPage Today) — Use of immune checkpoint inhibitor (ICI) therapy for cancer was associated with a significant reduction in actinic keratoses in a small prospective cohort study, indicating potential as an immuno-preventive strategy for high…
Source link : https://www.medpagetoday.com/dermatology/skincancer/114313
Author :
Publish date : 2025-02-22 15:00:00
Copyright for syndicated content belongs to the linked Source.
